These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 21144297)

  • 1. [Anti-angiogenic effects of low-dose gemcitabine combined with ginsenoside Rg3 on mouse Lewis lung carcinoma].
    Huang X; Hou M; Yi C; Song H
    Zhongguo Fei Ai Za Zhi; 2006 Apr; 9(2):132-6. PubMed ID: 21144297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice.
    Liu TG; Huang Y; Cui DD; Huang XB; Mao SH; Ji LL; Song HB; Yi C
    BMC Cancer; 2009 Jul; 9():250. PubMed ID: 19624862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental study on anti-angiogenesis in mice with Lewis lung carcinoma by low-dose of cyclophosphamide combined with ginsenoside Rg3].
    Kang XM; Zhang QY; Tong DD; Zhao W
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Aug; 25(8):730-3. PubMed ID: 16152834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic effect of low-dose cyclophosphamide combined with ginsenoside Rg3 on Lewis lung carcinoma.
    Zhang Q; Kang X; Zhao W
    Biochem Biophys Res Commun; 2006 Apr; 342(3):824-8. PubMed ID: 16499874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitory Effect of Ginsenoside Rg3 Combined With 5-Fluorouracil on Tumor Angiogenesis and Tumor Growth of Colon Cancer in Mice: An Experimental Study].
    Zhao Y; Deng L; Cao Y; Ma B; Li Y; Xu J; Li H; Huang Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 55(1):111-117. PubMed ID: 38322531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer.
    Xu TM; Xin Y; Cui MH; Jiang X; Gu LP
    Chin Med J (Engl); 2007 Apr; 120(7):584-8. PubMed ID: 17442207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preliminary study for the roles and mechanisms of 20(R)-ginsenoside Rg3 and PEG-PLGA-Rg3 nanoparticles in the Lewis lung cancer mice].
    Geng L; Fan J; Gao QL; Yu J; Hua BJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Jun; 48(3):496-501. PubMed ID: 27318914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined low-dose chemotherapy inhibiting angiogenesis and growth of Lewis lung cancinoma xenografts in mice].
    Qiu M; Yi C; Hou M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):534-7. PubMed ID: 16909595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis.
    Xu TM; Cui MH; Xin Y; Gu LP; Jiang X; Su MM; Wang DD; Wang WJ
    Chin Med J (Engl); 2008 Aug; 121(15):1394-7. PubMed ID: 18959116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
    Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor and anti-angiogenic effects of Phyllanthus urinaria in mice bearing Lewis lung carcinoma.
    Huang ST; Yang RC; Lee PN; Yang SH; Liao SK; Chen TY; Pang JH
    Int Immunopharmacol; 2006 Jun; 6(6):870-9. PubMed ID: 16644472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of apoptosis-related gene expression in different serum level of insulin-like growth factor-1 in mice breast cancer tissue].
    Tang HB; Ye ZR; Ren YP; Zhang S; Chen GQ; Wu YP
    Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):1018-21. PubMed ID: 19035207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenoside Rg3 increases gemcitabine sensitivity of pancreatic adenocarcinoma via reducing ZFP91 mediated TSPYL2 destabilization.
    Pan H; Yang L; Bai H; Luo J; Deng Y
    J Ginseng Res; 2022 Sep; 46(5):636-645. PubMed ID: 36090681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis.
    Zhang L; Yu D; Hicklin DJ; Hannay JA; Ellis LM; Pollock RE
    Cancer Res; 2002 Apr; 62(7):2034-42. PubMed ID: 11929822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside Rg3 enhances the inhibitory effects of chemotherapy on esophageal squamous cell carcinoma in mice.
    Chang L; Huo B; Lv Y; Wang Y; Liu W
    Mol Clin Oncol; 2014 Nov; 2(6):1043-1046. PubMed ID: 25279195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study for the targeting therapy of mouse lung carcinoma treated by anti-hnRNPB1 monoclonal antibody with 131I].
    Chen MY; Li WM; Xu D; Chen WB
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 38(5):766-9. PubMed ID: 17953353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of platinum antitumor effects in human lung tumor xenografts by the angiogenesis inhibitor squalamine: effects on tumor neovascularization.
    Schiller JH; Bittner G
    Clin Cancer Res; 1999 Dec; 5(12):4287-94. PubMed ID: 10632372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of copper-chelating agent, trientine, and methotrexate attenuates colorectal carcinoma development and angiogenesis in mice.
    Yoshiji H; Yoshii J; Kuriyama S; Ikenaka Y; Noguchi R; Yanase K; Namisaki T; Kitade M; Yamazaki M; Fukui H
    Oncol Rep; 2005 Jul; 14(1):213-8. PubMed ID: 15944792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM
    Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.